February 01, 2015 6:50 AM ET

Pharmaceuticals

Company Overview of King Pharmaceuticals LLC

Company Overview

King Pharmaceuticals LLC research and develops, manufactures, markets, and sells prescription pharmaceutical products and animal health products worldwide. It offers branded prescription pharmaceuticals, which include neuroscience products, such as Skelaxin, Flector Patch, Avinza, and Embeda; hospital products, including Thrombin-JMI; and legacy products consisting of Levoxyl, Bicillin, Altace, and Cytomel to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons, and hospitals. The company’s animal health business focuses on medicated feed additives and water-soluble therapeutics, which are anti-infective products primarily for poultry, cattle, ...

501 Fifth Street

Bristol, TN 37620

United States

Founded in 1993

2,640 Employees

Phone:

423-989-8000

Fax:

423-274-8677

Key Executives for King Pharmaceuticals LLC

Chief Financial Officer and Principal Accounting Officer
Age: 58
President of Alpharma Animal Health
Age: 57
Executive Vice President and President of Meridian
Executive Vice President of Technical Operations
Executive Vice President of Engineering
Compensation as of Fiscal Year 2014.

King Pharmaceuticals LLC Key Developments

King Pharmaceuticals LLC to Pay $2.2 Million Civil Penalty

King Pharmaceuticals LLC will pay $2.2 million and take measures to comply with the Clean Air Act to resolve alleged violations of the Clean Air Act (CAA) at its pharmaceutical manufacturing facility located in Bristol, Tenn., announced the Department of Justice, the U.S. Environmental Protection Agency (EPA), and the Tennessee Department of Environment and Conservation (TDEC). From the $2.2 million civil penalty, $1.1 million will be paid to the United States and $1.1 million will be paid to TDEC. From TDECs $1.1 million penalty, $650,000 will be applied to a TDEC state project for homeowners. The settlement also requires the facility to demonstrate compliance with CAA National Emission Standards for Pharmaceuticals Production (PharmaMACT regulations) and to apply for a Title V permit.

Similar Private Companies By Industry

Company Name Region
Topiderm Inc. United States
Russ Pharmaceuticals United States
ALIGN Pharmaceuticals, LLC United States
Wockhardt USA, Inc. United States
Smart Items, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact King Pharmaceuticals LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.